E-cigarettes versus nicotine-replacement therapy for smoking cessation

New England Journal of Medicine

Volumn 380, Issue 20, 2019, Pages 1973-

  Zhang, Yuqing ^a   Upson, Dona ^b  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; VARENICLINE; NICOTINE;

FOOD AND DRUG ADMINISTRATION; HUMAN; LETTER; NICOTINE REPLACEMENT THERAPY; PRIORITY JOURNAL; SMOKING CESSATION; TREATMENT DURATION; VAPING; ELECTRONIC CIGARETTE; TOBACCO DEPENDENCE;

ELECTRONIC NICOTINE DELIVERY SYSTEMS; HUMANS; NICOTINE; SMOKING CESSATION; TOBACCO USE CESSATION DEVICES; TOBACCO USE DISORDER;

EID: 85065848188     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1903758     Document Type: Letter

References (5)

1. Hajek P, Phillips-Waller A, Przulj D, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med 2019;380:629-37.
2. Borrelli B, O'Connor GT. E-cigarettes to assist with smoking cessation. N Engl J Med 2019;380:678-9.
3. Tonstad S, Tønnesen P, Hajek P, Williams KE, Billing CB, Reeves KR. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA 2006; 296:64-71.
4. Drazen JM, Morrissey S, Campion EW. The dangerous flavors of e-cigarettes. N Engl J Med 2019;380:679-80.
5. Stratton K, Kwan LY, Eaton DL, eds. Public health consequences of e-cigarettes. Washington, DC: National Academies Press, January 2018.